139 related articles for article (PubMed ID: 30352067)
1. Impact of the time to achieve viral control on the dynamics of circulating HIV-1 reservoir in vertically infected children with long-term sustained virological suppression: A longitudinal study.
Moragas M; Distefano M; Mecikovsky D; Arazi Caillaud S; Cernadas C; Bologna R; Aulicino P; Mangano A
PLoS One; 2018; 13(10):e0205579. PubMed ID: 30352067
[TBL] [Abstract][Full Text] [Related]
2. Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection.
Uprety P; Patel K; Karalius B; Ziemniak C; Chen YH; Brummel SS; Siminski S; Van Dyke RB; Seage GR; Persaud D;
Clin Infect Dis; 2017 Jun; 64(11):1471-1478. PubMed ID: 28329153
[TBL] [Abstract][Full Text] [Related]
3. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
Uprety P; Chadwick EG; Rainwater-Lovett K; Ziemniak C; Luzuriaga K; Capparelli EV; Yenokyan G; Persaud D
Clin Infect Dis; 2015 Dec; 61(12):1862-70. PubMed ID: 26270687
[TBL] [Abstract][Full Text] [Related]
4. Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in Infants.
McManus M; Mick E; Hudson R; Mofenson LM; Sullivan JL; Somasundaran M; Luzuriaga K;
PLoS One; 2016; 11(4):e0154391. PubMed ID: 27104621
[TBL] [Abstract][Full Text] [Related]
5. Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression.
Bull ME; McKernan JL; Styrchak S; Kraft K; Hitti J; Cohn SE; Tapia K; Deng W; Holte S; Mullins JI; Coombs RW; Frenkel LM
AIDS Res Hum Retroviruses; 2019 Jun; 35(6):557-566. PubMed ID: 30892052
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
[TBL] [Abstract][Full Text] [Related]
7. Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children.
Saitoh A; Hsia K; Fenton T; Powell CA; Christopherson C; Fletcher CV; Starr SE; Spector SA
J Infect Dis; 2002 May; 185(10):1409-16. PubMed ID: 11992275
[TBL] [Abstract][Full Text] [Related]
8. HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment.
Luzuriaga K; Tabak B; Garber M; Chen YH; Ziemniak C; McManus MM; Murray D; Strain MC; Richman DD; Chun TW; Cunningham CK; Persaud D
J Infect Dis; 2014 Nov; 210(10):1529-38. PubMed ID: 24850788
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection.
Brussel A; Mathez D; Broche-Pierre S; Lancar R; Calvez T; Sonigo P; Leibowitch J
AIDS; 2003 Mar; 17(5):645-52. PubMed ID: 12646786
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART.
Lombardi F; Belmonti S; Rapone L; Borghetti A; Ciccullo A; Gagliardini R; Baldin G; Montagnani F; Moschese D; Emiliozzi A; Rossetti B; De Luca A; Di Giambenedetto S
J Clin Virol; 2018 Jun; 103():57-62. PubMed ID: 29656086
[TBL] [Abstract][Full Text] [Related]
11. Decay of human immunodeficiency virus type 1 unintegrated DNA containing two long terminal repeats in infected individuals after 3 to 8 years of sustained control of viremia.
McDermott JL; Martini I; Ferrari D; Bertolotti F; Giacomazzi C; Murdaca G; Puppo F; Indiveri F; Varnier OE
J Clin Microbiol; 2005 Oct; 43(10):5272-4. PubMed ID: 16207994
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic prediction of HIV-1 DNA decay: a multicenter longitudinal cohort study.
Yue Y; Li Y; Cui Y; Wang N; Huang Y; Cao W; Han Y; Zhu T; Lyu W; Xie J; Song X; Li Y; Wang T; Zhu T; Li T
BMC Infect Dis; 2021 Jun; 21(1):592. PubMed ID: 34157979
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.
Besson GJ; Lalama CM; Bosch RJ; Gandhi RT; Bedison MA; Aga E; Riddler SA; McMahon DK; Hong F; Mellors JW
Clin Infect Dis; 2014 Nov; 59(9):1312-21. PubMed ID: 25073894
[TBL] [Abstract][Full Text] [Related]
14. Quantitative HIV-1-specific antibodies as predictors of peripheral blood cell-associated HIV-1 DNA concentrations.
McManus M; Karalius B; Patel K; Persaud D; Luzuriaga K;
AIDS; 2020 Jul; 34(8):1117-1126. PubMed ID: 32287055
[TBL] [Abstract][Full Text] [Related]
15. Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA.
Laanani M; Ghosn J; Essat A; Melard A; Seng R; Gousset M; Panjo H; Mortier E; Girard PM; Goujard C; Meyer L; Rouzioux C;
Clin Infect Dis; 2015 Jun; 60(11):1715-21. PubMed ID: 25737374
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
Frange P; Faye A; Avettand-Fenoël V; Bellaton E; Descamps D; Angin M; David A; Caillat-Zucman S; Peytavin G; Dollfus C; Le Chenadec J; Warszawski J; Rouzioux C; Sáez-Cirión A;
Lancet HIV; 2016 Jan; 3(1):e49-54. PubMed ID: 26762993
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Ignacio RAB; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 34841369
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Bender Ignacio RA; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N;
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 35544209
[TBL] [Abstract][Full Text] [Related]
19. The effects of antiretroviral therapy initiation time on HIV reservoir size in Chinese chronically HIV infected patients: a prospective, multi-site cohort study.
Luo L; Wang N; Yue Y; Han Y; Lv W; Liu Z; Qiu Z; Lu H; Tang X; Zhang T; Zhao M; He Y; Shenghua H; Wang M; Li Y; Huang S; Li Y; Liu J; Tuofu Z; Routy JP; Li T
BMC Infect Dis; 2019 Mar; 19(1):257. PubMed ID: 30871484
[TBL] [Abstract][Full Text] [Related]
20. Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS.
Panther LA; Coombs RW; Zeh JE; Collier AC; Corey L
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):303-13. PubMed ID: 9525430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
